| Product Code: ETC323701 | Publication Date: Aug 2022 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continued to import Enrofloxacin primarily from India, Ireland, Canada, Germany, and China. The market showed a low concentration with a Herfindahl-Hirschman Index (HHI) remaining stable. The compound annual growth rate (CAGR) over the period 2020-2024 was modest at 1.33%, while the growth rate from 2023 to 2024 saw a significant spike of 12.52%. This indicates a growing demand for Enrofloxacin imports in the US market, potentially driven by factors such as increasing awareness of animal health and the need for veterinary pharmaceuticals.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Enrofloxacin Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Enrofloxacin Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Enrofloxacin Market - Industry Life Cycle |
3.4 United States (US) Enrofloxacin Market - Porter's Five Forces |
3.5 United States (US) Enrofloxacin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Enrofloxacin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Enrofloxacin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in animals |
4.2.2 Rising demand for animal protein products |
4.2.3 Growing adoption of enrofloxacin for veterinary use |
4.3 Market Restraints |
4.3.1 Stringent regulations on the use of antibiotics in livestock |
4.3.2 Emergence of antibiotic-resistant strains |
4.3.3 High cost of enrofloxacin production |
5 United States (US) Enrofloxacin Market Trends |
6 United States (US) Enrofloxacin Market, By Types |
6.1 United States (US) Enrofloxacin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Enrofloxacin Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 United States (US) Enrofloxacin Market Revenues & Volume, By Type I, 2021 - 2031F |
6.1.4 United States (US) Enrofloxacin Market Revenues & Volume, By Type II, 2021 - 2031F |
6.2 United States (US) Enrofloxacin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Enrofloxacin Market Revenues & Volume, By Application I, 2021 - 2031F |
6.2.3 United States (US) Enrofloxacin Market Revenues & Volume, By Application II, 2021 - 2031F |
7 United States (US) Enrofloxacin Market Import-Export Trade Statistics |
7.1 United States (US) Enrofloxacin Market Export to Major Countries |
7.2 United States (US) Enrofloxacin Market Imports from Major Countries |
8 United States (US) Enrofloxacin Market Key Performance Indicators |
8.1 Number of new product approvals for enrofloxacin in veterinary medicine |
8.2 Adoption rate of enrofloxacin in different animal species |
8.3 Research and development investments in enrofloxacin alternatives |
8.4 Number of reported cases of antibiotic-resistant infections in animals |
9 United States (US) Enrofloxacin Market - Opportunity Assessment |
9.1 United States (US) Enrofloxacin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Enrofloxacin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Enrofloxacin Market - Competitive Landscape |
10.1 United States (US) Enrofloxacin Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Enrofloxacin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |